Johnson & Johnson Thrives in Healthcare Sector with Strong Q3 Earnings and Strategic Moves

# Johnson & Johnson Stock Analysis: Growth, Strategy & Investment Potential in 2025 Dive into our latest podcast episode where we analyze Johnson & Johnson's current market position as of October 21, 2025. Discover why J&J's stock price is holding strong at $193.25 per share and what's behind the higher-than-average trading volumes exceeding 8 million shares. We break down their impressive Q3 2025 earnings that surpassed expectations with $2.80 per share—a 15.7% year-over-year increase—and examine how their innovative medicine and MedTech segments are driving growth. Learn about J&J's strategic orthopedics business spin-off and why analysts maintain a "moderate buy" consensus with price targets up to $215. Whether you're considering J&J for its stable performance or attractive 2.68% dividend yield, this episode provides essential insights for healthcare sector investors looking to make informed decisions in today's market. For more http://www.quietplease.ai Stock up on these deals https://amzn.to/3QFpYIX This content was created in partnership and with the help of Artificial Intelligence AI.